Program ID: 1715

You're invited to attend a Virtual Tarsus Peer to Peer Experience!

Date & Time

Wednesday, September 23, 2026
12:15 PM PT

Location

Virtual Program

Speaker(s)

Nicole Fram , MD Advanced Vision Care Los Angeles , CA
Nathan Lighthizer , OD NSU Oklahoma College of Optometry Tahlequah , OK
  • Demodex Blepharitis Today: New Data and Real-World Insight

Program Host(s)

Bryan Eckstein

Program Coordinator

Sean Openshaw
(732) 852-9617

sopenshaw@medforce.net

* These fields are required.

Indication and Important Safety Information

Expand

INDICATIONS AND USAGE

XDEMVY is indicated for the treatment of Demodex blepharitis.

Important Safety Information:

WARNINGS AND PRECAUTIONS

Risk of Contamination: Do not allow the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

ADVERSE REACTIONS: The most common adverse reaction with XDEMVY was instillation site stinging and burning which was reported in 10% of patients. Other ocular adverse reactions reported in less than 2% of patients were chalazion/hordeolum and punctate keratitis.

Please see the Full Prescribing Information.